F2 and deep vein thrombosis: Importantly, FV Leiden carriers are four times more likely to experience recurrent thrombosis, and this finding is further extended to those individuals carrying the compound FV Leiden and prothrombin G20210A mutations, as they are 40% more prone to recurrence of thrombosis and having the first episode under the age of 45 years [7,41].